Get 30% off on all global market reports with code ONLINE30 – stay updated on tariff changes, macroeconomic trends, and more!
Oxycodone Drugs Market Size Expansion: A Snapshot of Growth Between 2024 and 2029
In the past few years, there has been notable growth in the oxycodone drugs market. This market is projected to continue growing from a value of $5.62 billion in 2024, reaching $6.04 billion in 2025, with a compound annual growth rate (CAGR) of 7.4%.
The significant growth experienced during the historical period can be attributed to an assertive marketing campaign for oxycontin. This drug was marketed for treating chronic non-malignant pain and cancer which led to an increase in the number of oxycontin prescriptions for non-cancer pain and as a result, boosted the demand for these drugs.
Furthermore, synthetic opiates like oxycodone became more prevalent in the market after the second world war.
Over the coming years, the oxycodone drugs market is projected to experience significant growth, increasing to $7.92 billion in 2029 at a compound annual growth rate (CAGR) of 7.0%. This potential growth during the forecast period is due to reasons such as an escalated prevalence of chronic pain, an uptick in the number of surgical procedures, continuous product pipeline development, advanced drug delivery systems, and an expanding global elderly population suffering from an increased frequency of chronic pain.
Future market trends encompass a higher demand for abuse-deterrent formulations (ADFS), the creation of innovative delivery systems, the increased usage of combination therapies, and improvements in technology within the manufacturing process.
Claim Your Free Sample Report:
http://www.thebusinessresearchcompany.com/sample….p;type=smp
Key Drivers Behind the Expansion of the Oxycodone Drugs Market: Insights and Trends
The significant rate of orthopedic conditions is anticipated to boost the oxycodone drug market’s expansion in the future. These disorders cover various musculoskeletal complications like issues with bones, joints, ligaments, tendons, and muscles, often causing pain, restricted movement, and functional hindrances.
Factors contributing to the increasing prevalence of orthopedic issues include aging populations, lack of physical activity, obesity, sports injuries, and work-related risks. Oxycodone medications are often employed to ease acute and chronic pain from complications such as fractures, joint damage, or discomfort post-surgery since they effectively offer relief by acting on the pain receptors within the central nervous system.
For example, according to the US-based research institute, the Institute for Health Metrics and Evaluation, in October 2023, the projected cases of musculoskeletal ailments (orthopedic disorders) are predicted to increase by 115% (between 107-124%) from 2020 to 2050, thereby reaching almost 1,060 million prevalent cases by 2050. Thus, the high incidence of orthopedic disorders is driving the oxycodone drug market’s growth.
Which Segments in the Oxycodone Drugs Industry Are Seeing the Fastest Growth?
The oxycodone drugs market covered in this report is segmented –
1) By Drug Type: Short Acting Oxycodone, Long Acting Oxycodone
2) By Dosage Form: Tablets, Capsules, Injections
3) By Indication: Neuropathic Pain, Musculoskeletal Pain, Cancer Pain, Post Operative Pain, Other Indications
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Short Acting Oxycodone: Immediate-Release Oxycodone Tablets, Oxycodone Oral Solution
2) By Long Acting Oxycodone: Extended-Release Oxycodone Tablets, Oxycodone Controlled-Release Formulations
Access the Full Report Today:
http://www.thebusinessresearchcompany.com/report/…ket-report
Which New Trends Will Create Growth Opportunities in the Oxycodone Drugs Market?
Leading companies in the oxycodone drug market are concentrating on the development of novel drugs such as oxycodone immediate-release (IR) tablets with the aim to curtail drug misuse through injection and intranasal approaches. Oxycodone immediate-release (IR) tablets are a version of the opioid painkiller oxycodone structured to offer prompt pain alleviation.
As an example, Protega Pharmaceuticals LLC, a pharmaceutical firm based in the United States, introduced RoxyBond (oxycodone) immediate-release (IR) tablets in the United States in July 2022. The U.S. Food and Drug Administration (FDA) has given authorization to RoxyBond as an opioid receptor stimulant for the control of severe pain which necessitates an opioid painkiller when other alternatives are inadequate.
The drug is crafted with leading-edge technology to prevent misuse and abuse, making it challenging to alter either physically or chemically.
Which Global Regions Are Powering Demand in the Oxycodone Drugs Market?
North America was the largest region in the oxycodone drugs market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period.
The regions covered in the oxycodone drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Get a Customized Version of the Report:
http://www.thebusinessresearchcompany.com/customi…p;type=smp
How Key Players Are Driving Growth in the Oxycodone Drugs Market?
Major companies operating in the oxycodone drugs market are Pfizer Inc., Johnson & Johnson Services Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Ltd., Purdue Pharma L.P, Endo International plc, Amneal Pharmaceuticals LLC, Mundipharma Pty Limited, Alkermes plc, Mallinckrodt Pharmaceuticals, Alvogen Group Inc., Collegium Pharmaceutical Inc., Lannett Company Inc., Acorda Therapeutics Inc., Camurus AB, Rhodes Pharmaceuticals L.P., KVK Tech Inc., Teikoku Pharma USA Inc., Manus Aktteva Biopharma LLP, Zyla Life Sciences
Access the Complete Report:
http://www.thebusinessresearchcompany.com/purchas…x?id=15886
How Our Market Research Reports Help Maximize ROI Across Industries:
* Identify High-Growth Opportunities: Pinpoint emerging trends, untapped segments, and regional hotspots that align with your strategic goals.
* Reduce Investment Risk: Make data-driven decisions with confidence by understanding market dynamics, key drivers, and competitive threats.
* Optimize Strategic Planning: Align your product development, marketing, and expansion plans with industry forecasts and customer behaviour insights.
News From
The Business Research Company …
Category: Industry Reports & Market Analysis Profile: The Business Research Company is a leading market research and consulting services provider. It offers over 9,500 market reports across 27 industries in 60+ geographies, providing detailed insights and forecasts. Its customised research solutions support companies in making critical decisions, while its continuous research service enhances organizational capabilities. The flagship Global Market Model database provides comprehensive market intelligence with 1,500,000 datasets covering 8,000+ mark …
This email address is being protected from spambots. You need JavaScript enabled to view it.
